Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.

27 Interference of Concomitant Antigen Responses In our study, a birth dose of the aP vaccine resulted in significantly reduced GMCs to the concomitant antigens Hib, diphtheria, and tetanus at 32 weeks; the proportion above the protective threshold was lower but did not reach statistical significance for hepatitis B.

also in 111,027 other papers